Wyden, Crapo, Menendez, Blackburn, Tester and Marshall Introduce Bipartisan Legislation to Reform PBMs and Bring Down the Cost of Prescription Drugs

Press Release

"As we work to find solutions that reduce prescription drug costs for patients at the pharmacy counter, this commonsense proposal will help mitigate misaligned incentives that currently steer some Medicare Part D plans, pharmacy benefit managers and seniors toward higher-priced medications, even when more affordable alternatives like biosimilars are on the market. Delinking PBM compensation from sticker prices would take a critical first step in ensuring that all supply chain participants seek out the best deals available, driving down out-of-pocket spending and promoting cost-cutting competition. I look forward to continuing our committee's bipartisan efforts to advance comprehensive, patient-focused policies moving forward."

Source